Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The STAR*D study: treating depression in the real world.

Literature DB >> 18236731

The STAR*D study: treating depression in the real world.

Bradley N Gaynes¹, A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Donald Spencer, Maurizio Fava.

Abstract

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study evaluated feasible treatment strategies to improve clinical outcomes for real-world patients with treatment-resistant depression. Although the study found no clear-cut "winner", it does provide guidance on how to start therapy and how to proceed if initial treatment fails.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2008 PMID： 18236731 DOI： 10.3949/ccjm.75.1.57

Source DB: PubMed Journal: Cleve Clin J Med ISSN： 0891-1150 Impact factor: 2.321

Keyword Cloud
Cited

52 in total

Review 1. Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Authors: Nolan R Williams; Michael S Okun
Journal: J Clin Invest Date: 2013-11-01 Impact factor: 14.808

Review 2. Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors: Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal: Mol Diagn Ther Date: 2008 Impact factor: 4.074

10. Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies.

Authors: C Anthony Altar; Joseph Carhart; Josiah D Allen; Daniel Hall-Flavin; Joel Winner; Bryan Dechairo
Journal: Mol Neuropsychiatry Date: 2015-07-31

The STAR*D study: treating depression in the real world.

Review 1. Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Review 2. Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

3. The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.

4. Feasible evidence-based strategies to manage depression in primary care.

5. miR-17-92 Cluster Regulates Adult Hippocampal Neurogenesis, Anxiety, and Depression.

6. SEMIPARAMETRIC REGRESSION ANALYSIS OF REPEATED CURRENT STATUS DATA.

7. Depression in cardiovascular disease: From awareness to action.

8. Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Review 9. Depression and Parkinson's disease: current knowledge.

10. Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies.